News Stories (2 Results) -
Medexus Pharmaceuticals
Medexus Pharmaceuticals entered into a new senior secured credit agreement agented by BMO. The credit agreement provides for a US$35 million term loan facility and a US$3.5 million revolving loan facility for working capital. The term loan facility...
Read Story
March 09, 2023, 07:45 AM
|
Medexus Pharmaceuticals entered into an amendment to the company’s revolving credit facility with a syndicate of lenders agented by MidCap Funding IV Trust (MidCap). Among other things, the amendment provides for a US$5.0 million increase in MidCap’s...
Read Story
September 30, 2022, 07:29 AM
|